These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 31911031

  • 1. Evaluation of the protective efficacy of recombinant protective antigen vaccine (GC1109)-immunized human sera using passive immunization in a mouse model.
    Jo SK, Ahn BE, Choi EH, Kang JE, An H, Oh MD, Rhie GE.
    Vaccine; 2020 Feb 11; 38(7):1586-1588. PubMed ID: 31911031
    [Abstract] [Full Text] [Related]

  • 2. Immunogenicity and Protective Efficacy of Recombinant Protective Antigen Anthrax Vaccine (GC1109) in A/J Mice Model.
    Kim GL, Pyo SW, Yi H, Kim SH, Shin H, Yu MA, Hwang YR, Choi SY, Jeon JH, Jo SK, Rhie GE.
    Vaccine; 2023 May 05; 41(19):3106-3110. PubMed ID: 37055344
    [Abstract] [Full Text] [Related]

  • 3. Use of the mice passive protection test to evaluate the humoral response in goats vaccinated with Sterne 34F2 live spore vaccine.
    Phaswana PH, Ndumnego OC, Koehler SM, Beyer W, Crafford JE, van Heerden H.
    Vet Res; 2017 Sep 07; 48(1):46. PubMed ID: 28882176
    [Abstract] [Full Text] [Related]

  • 4. BA3338, a surface layer homology domain possessing protein augments immune response and protection efficacy of protective antigen against Bacillus anthracis in mouse model.
    Kumar M, Puranik N, Varshney A, Tripathi N, Pal V, Goel AK.
    J Appl Microbiol; 2020 Aug 07; 129(2):443-452. PubMed ID: 32118336
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen.
    Peachman KK, Rao M, Alving CR, Burge R, Leppla SH, Rao VB, Matyas GR.
    Infect Immun; 2006 Jan 07; 74(1):794-7. PubMed ID: 16369043
    [Abstract] [Full Text] [Related]

  • 7. Comparative analysis of the immunologic response induced by the Sterne 34F2 live spore Bacillus anthracis vaccine in a ruminant model.
    Ndumnego OC, Köhler SM, Crafford J, van Heerden H, Beyer W.
    Vet Immunol Immunopathol; 2016 Oct 01; 178():14-21. PubMed ID: 27496738
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin.
    Gaur R, Gupta PK, Banerjea AC, Singh Y.
    Vaccine; 2002 Jun 21; 20(21-22):2836-9. PubMed ID: 12034111
    [Abstract] [Full Text] [Related]

  • 11. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S, Hinchcliffe M, Petrie CR, Warwood SJ, Tino WT, Williams MS, Stenz JP, Cheff A, Richardson C.
    Vaccine; 2006 May 01; 24(18):3953-63. PubMed ID: 16530302
    [Abstract] [Full Text] [Related]

  • 12. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
    Welkos S, Little S, Friedlander A, Fritz D, Fellows P.
    Microbiology (Reading); 2001 Jun 01; 147(Pt 6):1677-1685. PubMed ID: 11390699
    [Abstract] [Full Text] [Related]

  • 13. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
    Bielinska AU, Janczak KW, Landers JJ, Makidon P, Sower LE, Peterson JW, Baker JR.
    Infect Immun; 2007 Aug 01; 75(8):4020-9. PubMed ID: 17502384
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits.
    Lee DY, Chun JH, Ha HJ, Park J, Kim BS, Oh HB, Rhie GE.
    FEMS Immunol Med Microbiol; 2009 Nov 01; 57(2):165-72. PubMed ID: 19732139
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intranasal administration of dry powder anthrax vaccine provides protection against lethal aerosol spore challenge.
    Huang J, Mikszta JA, Ferriter MS, Jiang G, Harvey NG, Dyas B, Roy CJ, Ulrich RG, Sullivan VJ.
    Hum Vaccin; 2007 Nov 01; 3(3):90-3. PubMed ID: 17375001
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax.
    Williamson ED, Hodgson I, Walker NJ, Topping AW, Duchars MG, Mott JM, Estep J, Lebutt C, Flick-Smith HC, Jones HE, Li H, Quinn CP.
    Infect Immun; 2005 Sep 01; 73(9):5978-87. PubMed ID: 16113318
    [Abstract] [Full Text] [Related]

  • 20. Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization.
    Li H, Soroka SD, Taylor TH, Stamey KL, Stinson KW, Freeman AE, Abramson DR, Desai R, Cronin LX, Oxford JW, Caba J, Pleatman C, Pathak S, Schmidt DS, Semenova VA, Martin SK, Wilkins PP, Quinn CP.
    J Immunol Methods; 2008 Apr 20; 333(1-2):89-106. PubMed ID: 18304568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.